Autologous Stem Cell Transplantation in Patients with Primary Amyloidosis: A Nation-wide Survey

References

• Skinner, M., Anderson, J., Simms, R., Falk, R., Wang, M., Libbey, C., et al. (1996) "Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine alone", American Journal of Medicine, 100,~! 290–298.
   PubMed Web of Science ®Google Scholar
• Kyle, R.A., Gertz, M.A., Greipp, P.R., Witzig, T.E., Lust, J.A., Lacy, M.Q., et al. (1997) "A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine", New England Journal of Medicine, 336, 1202— 1207.
   Google Scholar
• Majolino, I., Marceno, R., Pecoraro, G., Scime, R., Vasta, S., Liberti, G., et al. (1993) "Autologous stem cell transplantation in amyloidosis AL", Bone Marrow Transplantation, 11, 85.
   PubMed Web of Science ®Google Scholar
• Comenzo, R.L., Vosburgh, E., Simms, R.W., Bergethon, P., Sarnacki, D., Finn, K., et al. (1996) "Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients", Blood, 88, 2801–2806.
   Google Scholar
• Comenzo, R.L., Vosburgh, E., Falk, R.H., Sanchorawala, V., Reisinger, J., Dubrey, S., et al. (1998) "Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients", Blood, 91, 3662–3670.
   PubMed Web of Science ®Google Scholar
• Moreau, P., Leblond, V., Bourquelot, P., Facon, T., Huynh, A., Caillot, D., et al. (1998) "Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic amyloidosis: a report of 21 cases", British Journal of Haematology, 101, 766–869.
   PubMed Web of Science ®Google Scholar
• Gertz, M.A., Lacy, M.Q., Gastineau, D.A., Inwards, D.J., Chen, M.G., Tefferi, A., et al. (2000) "Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)", Bone Marrow Transplantation, 26, 963–969.
   PubMed Web of Science ®Google Scholar
• Gertz, M.A., Lacy, M.Q., Dispenzieri, A., Gastineau, D.A., Chen, M.G., Ansell, S.M., et al. (2002) "Stem cell transplantation for the management of primary systemic amyloidosis", American Journal of Medicine, 113, 549–555.
   Google Scholar
• Gertz, M.A., Lacy, M.Q. and Dispenzieri, A. (2000) "Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report", Bone Marrow Transplanta-tion, 25, 465–470.
   PubMed Web of Science ®Google Scholar
• Sanchorawala, V., Wright, D.C., Seldin, D.C., Dember, L.M., Finn, K., Falk, R.H., et al. (2001) "An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis", Bone Marrow Transplantation, 28, 637— 642.
   Google Scholar
• Comenzo, R.L. and Gertz, M.A. (2002) "Autologous stem cell transplantation for primary systemic amyloidosis", Blood, 99, 4276 — 4282.
   Google Scholar
• Gertz, M.A., Kyle, R.A. and Greipp, P.R. (1991) "Response rates and survival in primary systemic amyloidosis", Blood, 77, 257— 262.
   Google Scholar
• Mollee, P.N., Wechalekar, A.D., Pereira, D.L., Franke, N., Reece, D., Chen, C., et al. (2004) "Autologous stem cell transplantation (ASCT) in primary systemic amyloidosis: the impact of selection criteria to outcome", Bone Marrow Transplantation, 33, 271–277.
   PubMed Web of Science ®Google Scholar
• Saba, N., Sutton, D., Ross, H., Siu, S., Crump, R., Keating, A., et al. (1999) "High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant", Bone Marrow Transplantation, 24, 853–855.
   Google Scholar
• Oran, B., Wright, D.C., Seldin, D.C., McAneny, D., Skinner, M. and Sanchorawala, V. (2003) "Spontaneous rupture of the spleen in AL amyloidosis", American Journal of Hematology, 74, 131–135.
   PubMed Web of Science ®Google Scholar
• Gertz, M.A., Lacy, M.Q., Bjornsson, J. and Litzow, M.R. (2000) "Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: a report and review of growth factor-induced pulmonary toxicity", Journal of Hematotherapy and Stem Cell Research, 9, 635–643.
   Google Scholar
• Rechner, I., Brito-Babapulle, F. and Fielden, J. (2003) "Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF)", Hematology Journal, 4, 54— 56.
   Google Scholar
• Reich, G., Held, T., Siegert, W., Kampf, D., Dorken, B. and Maschmeyer, G. (2001) "Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplanta-tion", Bone Marrow Transplantation, 27, 341–343.
   Google Scholar
• Skinner, M., Sanchorawala, V., Seldin, D.C., Dember, L.M., Falk, R.H., Berk, J.L., et al. (2004) "High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloi-dosis: an 8-year study", Annals of Internal Medicine, 140, 85–93.
   PubMed Web of Science ®Google Scholar
• Fadia, A., Casserly, L.F., Sanchorawala, V., Seldin, D.C., Wright, D.G., Skinner, M., et al. (2003) "Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis", Kidney International, 63, 1868–1873.
   Web of Science ®Google Scholar
• Kumar, S., Dispenzieri, A., Lacy, M.Q., Litzow, M.R. and Gertz, M.A. (2001) "High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis", Bone Marrow Transplantation, 28, 381–385.
   Google Scholar
• Casserly, L.F., Fadia, A., Sanchorawala, V., Seldin, D.C., Wright, D.C., Skinner, M., et al. (2003) "High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease", Kidney International, 63, 1051–1057.
   Google Scholar
• Dember, L.M., Sanchorawala, V., Seldin, D.C., Wright, D.C., LaValley, M., Berk, J.L., et al. (2001) "Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplanta-tion on AL amyloidosis-associated renal disease", Annals of Internal Medicine, 143, 746–753.
   Google Scholar
• Urbano-Ispizua, A., Schmitz, N., de Witte, T., Frassoni, F., Rosti, G., Scherezenmeier, H., et al. (2002) "Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe", Bone Marrow Transplantation, 29, 639–646.
   PubMed Web of Science ®Google Scholar
• Dispenzieri, A., Macy, M.Q., Kyle, R.A., Therneau, T.M., Larson, D.R., Rajkumar, S.V., et al. (2001) "Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favourable prognostic factor for survival", Journal of Clinical Oncology, 19, 3350— 3356.
   Google Scholar
• Dispenzieri, A., Kyle, R.A., Lacy, M.Q., Therneau, T.M., Larson, D.R., Plevak, M.F., et al. (2004) "Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplant: a case control study", Blood, 103, 3960–3963.
   Google Scholar